Stanford University Medical Center

Study explains why drug may help more cancer patients

(Medical Xpress)—Recently some intriguing data has suggested that breast cancer patients whose tumors appear insensitive to a class of drugs known as anti-HER2 medications (the drug trastuzumab, marketed as Herceptin, is ...

Nov 18, 2013
popularity not rated yet | comments 0 | with audio podcast